Precautions and Warnings With Golimumab

Golimumab has been known to cause dangerously low blood counts and certain types of infection in rare cases. Therefore, tell your healthcare provider about any unusual bruising, bleeding, or paleness while using golimumab. Warnings and precautions also extend to people with congestive heart failure, any infections, or any disease that affects the immune system.

What Should I Tell My Healthcare Provider?

Prior to using golimumab (Simponi™), talk to your healthcare provider if you have:
 
Also, let your healthcare provider know if you are:
 
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
     
Make sure to tell your healthcare provider about all of the medicines you take, including prescription and nonprescription medications, vitamins, and herbal supplements.
 

Specific Golimumab Warnings and Precautions

Some warnings and precautions to be aware of prior to using golimumab include the following:
 
  • Golimumab can increase your chance of infections, including serious infections. You should not start using this product if you have an infection -- even a skin infection. During treatment, be sure to tell your healthcare provider right away if you think you may have an infection. This medication may not be the best choice for people who get frequent infections.
     
  • This medicine can cause certain infections (such as hepatitis B or tuberculosis) that have become inactive in the body to become active again. Tell your healthcare provider if you have ever had hepatitis B or tuberculosis before starting treatment. Your healthcare provider should give you a tuberculosis skin test to make sure you have never had it.
     
  • There have been rare reports of lymphoma (a certain type of cancer) in people using golimumab or other medications similar to it. It is not yet known if the drug actually caused these cancers or not.
     
  • The needle cover of the prefilled syringes and the autoinjector contains dry natural rubber, which may cause allergic reactions in people with a latex allergy.
     
  • In studies, people with congestive heart failure (CHF) who took medications similar to golimumab had an increased risk of death. Also, worsening of heart failure and new cases of heart failure in people who did not already have it have been reported in people taking such medications. Talk to your healthcare provider about golimumab and congestive heart failure before taking it.
     
  • In rare cases, golimumab has caused dangerously low blood counts. You should tell your healthcare provider about any unusual bruising, bleeding, or paleness while using it.
     
  • You should not receive live vaccines while using golimumab. Talk to your healthcare provider before receiving any vaccines while on this product.
     
  • In rare cases, golimumab or medications like it have been reported to cause certain nervous system conditions, including multiple sclerosis (MS), optic neuritis, and Guillain-Barré syndrome. Golimumab could also make these conditions worse. Talk to your healthcare before beginning treatment if you have MS or any other nervous system condition.
     
  • Golimumab can potentially interact with a few other medications (see Drug Interactions With Golimumab).
     
  • Golimumab is considered a pregnancy Category B medication. This means that it is probably safe for use during pregnancy, although the full risks are not currently known (see Simponi and Pregnancy).
     
  • It is not known if golimumab passes through breast milk in humans. Therefore, if you are breastfeeding or plan to start, discuss this with your healthcare provider prior to taking the drug (see Simponi and Breastfeeding).
     
Top Foods to Fight Inflammation

Golimumab Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.